We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Demonstrates Novel Infectious Disease Testing Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is demonstrating its range of molecular diagnostic instruments and testing solutions for infectious diseases at the 2022 AACC Clinical Lab Expo, including its SAW-96 and SMPE-960 nucleic acid extraction systems, alongside the STC-96A and STC-96A PLUS real-time PCR systems.

The SAW-96 automated nucleic acid extraction workstation integrates cutting-edge mechanical, electronic, and software technologies. SAW-96 integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument and has typical run duration of less than 70 minutes for 1-96 samples. Based on magnetic separation technology, SAW-96 provides high throughput automation combined with high performance. The SMPE-960 nucleic acid extraction system integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Each module consists of 1-32 samples so that samples can be tested upon delivery.

The STC-96A and STC-96A PLUS real-time PCR systems offer stable performance and user-friendly design for molecular laboratories to identify viral and bacterial infections. In particular, the STC-96A Plus which is designed for real-time PCR analysis of gene expression and genetic variation allows two different PCR assays to be run on just one instrument with separate-controlled programs. Both the real-time PCR systems maintain a remarkable temperature uniformity of 0.1℃ across 96 wells, ensuring highly precise diagnostic results.

AT AACC 2022, Bioperfectus is also demonstrating its wide range of testing solutions for infectious diseases, including respiratory, sexually transmitted, vector-borne, gastrointestinal, and zoonotic. Among its respiratory infectious disease tests, Bioperfectus offers the COVID-19 Coronavirus real time PCR kit, COVID-19 Coronavirus (ORF1ab/N/E) real time PCR kit, Novel Corona Virus (SARS-CoV-2) Ag rapid test kit, Novel Corona Virus (SARS-CoV-2) IgM/IgG rapid test kit, Influenza A and B Viruses real time PCR kit, and COVID-19 Coronavirus and Influenza A/B Virus real time PCR kit. For sexually transmitted diseases, Bioperfectus offers the Human Papillomavirus Genotyping real time PCR kit, Neisseria Gonorrhoeae/Chlamydia Trachomatis/U. Urealyticum real time PCR kit and Chlamydia Trachomatis real time PCR kit, among others. In zoonotic diseases, Bioperfectus has recently launched the new Monkeypox Virus real time PCR kit based on real-time PCR technology. Specific primers and probes are designed based on F3L gene areas of the Monkeypox virus. In addition, the kit also contains a housekeeping gene (RNase P) as an internal control (IC) for specimen sampling and nucleic acid extraction.
 

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 


Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
New
Portable POCT Blood Gas Analyzer
BD100
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.